Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma (original) (raw)
Abstract
The relationship between interleukin 6 (IL-6) levels and clinical parameters was studied in 25 patients with malignant pleural mesothelioma. The serum levels of IL-6, C-reactive protein, alpha1-acid glycoprotein and fibrinogen were significantly higher in mesothelioma than in lung adenocarcinoma with cytology-positive pleural effusion. Serum IL-6 levels correlated with the levels of the acute-phase proteins. We demonstrated a high incidence of thrombocytosis (48%) and a significant correlation between platelet count and the serum IL-6 level. The level of IL-6 in the pleural fluid of patients with mesothelioma was significantly higher than in the pleural fluid of patients with adenocarcinoma, and was about 60-1400 times higher than in the serum. However, even higher levels of IL-6 in the pleural fluid and of thrombocytosis were found in patients with tuberculous pleurisy. These results indicate that large amounts of IL-6 from the pleural fluid of patients with mesothelioma leak into the systemic circulation and induce clinical inflammatory reactions. These profiles are not specific to mesothelioma as similar profiles are found in patients with tuberculous pleurisy. However, the detection of a markedly increased level of IL-6 in pleural fluid argues against a diagnosis of adenocarcinoma.
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Third Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
T Nakano
Authors
- T Nakano
- AP Chahinian
- M Shinjo
- A Tonomura
- M Miyake
- N Togawa
- K Ninomiya
- K Higashino
Rights and permissions
About this article
Cite this article
Nakano, T., Chahinian, A., Shinjo, M. et al. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma.Br J Cancer 77, 907–912 (1998). https://doi.org/10.1038/bjc.1998.150
- Issue Date: 01 March 1998
- DOI: https://doi.org/10.1038/bjc.1998.150
This article is cited by
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
- Tsuyoshi Shirakawa
- Akitaka Makiyama
- Eishi Baba
Scientific Reports (2023)
Prognostication and monitoring of mesothelioma using biomarkers: a systematic review
- David T Arnold
- Duneesha De Fonseka
- Nick A Maskell
British Journal of Cancer (2017)
Thrombocytosis and Raised CRP Levels Predicts Advanced Stage in Esophageal Carcinoma
- G. R. Verma
- S. Thiagarajan
- S. K. Sinha
Journal of Gastrointestinal Cancer (2015)
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
- B Ghanim
- M A Hoda
- B Hegedus
British Journal of Cancer (2014)
Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis
- Arsen D. Ristić
- Sabine Pankuweit
- Bernhard Maisch
Heart Failure Reviews (2013)